Literature DB >> 9550321

Intracellular signal transduction mediated by ligation of MHC class I molecules.

S Skov1.   

Abstract

A great deal of knowledge has accumulated regarding signal transduction after ligation of MHC class I (MHC-I) molecules. In recent years focus has been given to delineation of the intracellular signal pathways activated after MHC-I ligation. Activation of tyrosine kinases leading to a rise in the intracellular free calcium concentration ([Ca2+]i) is the major initial event occurring after MHC-I ligation of T cells. Curiously, the MHC-I-induced signaling is not dependent upon the cytoplasmic tail of the MHC-I molecule, suggesting that the MHC-I molecule induces intracellular signaling through association with other membrane-embedded molecules. More distal signaling events after MHC-I ligation includes activation of the Jak/Stat pathway leading to Stat-3 activation, and activation of the PI3-kinase leading to JNK activation and apoptosis. This review will sum up what is currently known about signaling induced by ligation of MHC-I.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9550321

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  11 in total

1.  Constitutive MHC class I molecules negatively regulate TLR-triggered inflammatory responses via the Fps-SHP-2 pathway.

Authors:  Sheng Xu; Xingguang Liu; Yan Bao; Xuhui Zhu; Chaofeng Han; Peng Zhang; Xuemin Zhang; Weihua Li; Xuetao Cao
Journal:  Nat Immunol       Date:  2012-04-22       Impact factor: 25.606

2.  HLA-G is found in lipid rafts and can act as a signaling molecule.

Authors:  Martina Comiskey; Kenneth E Domino; Carol M Warner
Journal:  Hum Immunol       Date:  2006-11-03       Impact factor: 2.850

Review 3.  The link between major histocompatibility complex antibodies and cell proliferation.

Authors:  Nicole M Valenzuela; Elaine F Reed
Journal:  Transplant Rev (Orlando)       Date:  2011-07-30       Impact factor: 3.943

4.  Molecular events contributing to successful pediatric cardiac transplantation in HLA sensitized recipients.

Authors:  Monal Sharma; S A Webber; A Zeevi; T Mohanakumar
Journal:  Hum Immunol       Date:  2019-01-30       Impact factor: 2.850

Review 5.  Killing tumor cells through their surface beta(2)-microglobulin or major histocompatibility complex class I molecules.

Authors:  Jing Yang; Qing Yi
Journal:  Cancer       Date:  2010-04-01       Impact factor: 6.860

6.  Distinct spatial relationship of the interleukin-9 receptor with interleukin-2 receptor and major histocompatibility complex glycoproteins in human T lymphoma cells.

Authors:  Enikő Nizsalóczki; István Csomós; Péter Nagy; Zsolt Fazekas; Carolyn K Goldman; Thomas A Waldmann; Sándor Damjanovich; György Vámosi; László Mátyus; Andrea Bodnár
Journal:  Chemphyschem       Date:  2014-10-08       Impact factor: 3.102

7.  Characterization of the HLA-C*07:01:01G allele group in European and African-American cohorts.

Authors:  Zhihui Deng; Xiaojiang Gao; Gregory D Kirk; Steven Wolinsky; Mary Carrington
Journal:  Hum Immunol       Date:  2012-04-28       Impact factor: 2.850

8.  SDF-2 induction of terminal differentiation in Dictyostelium discoideum is mediated by the membrane-spanning sensor kinase DhkA.

Authors:  N Wang; F Söderbom; C Anjard; G Shaulsky; W F Loomis
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

9.  The transmembrane sequence of human histocompatibility leukocyte antigen (HLA)-C as a determinant in inhibition of a subset of natural killer cells.

Authors:  D M Davis; O Mandelboim; I Luque; E Baba; J Boyson; J L Strominger
Journal:  J Exp Med       Date:  1999-04-19       Impact factor: 14.307

10.  MHC-I molecules selectively inhibit cell-mediated cytotoxicity triggered by ITAM-coupled activating receptors and 2B4.

Authors:  Rubén Corral-San Miguel; Trinidad Hernández-Caselles; Antonio José Ruiz Alcaraz; María Martínez-Esparza; Pilar García-Peñarrubia
Journal:  PLoS One       Date:  2014-09-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.